Analysis of the main clinical and laboratory alterations and computed tomography scans in patients infected with sars-cov-2 in Maceió-Alagoas
Pandemic. Mr. Covid. Diaggnóstic. Effective treatments. Preventive methods.
The Coronavirus 19 pandemic (SARS-CoV-2) has brought great advances in research in medical areas worldwide, with a growing search for more appropriate diagnostic methods, effective treatments and preventive methods, such as vaccination, for example. The precise diagnosis of COVID-19 infection is made by laboratory examination known as RCT-PCR, which analyzes the presence of the virus in the nasal and oral cavities. Computed tomography of the chest has been assisting in the early diagnosis of pulmonary alterations resulting from COVID-19 and collaborates with the multidisciplinary team in the evaluation of the severity of the patient, favoring a more adequate conduction for each situation. Main objective is to correlate the main clinical, laboratory and imaging alterations in Computed Tomography in patients confirmed by SARS-COV-2 infection. One of the private hospitals in the state of Alagoas has a registry of 3456 patients confirmed for infection with COVID-19 through RT-PCR between March and December 2020, of these only 1568 have ct scans in the imaging database. Of these 1568, 430 patients were randomly selected and respecting the monthly proportionality of cases, but 40 were excluded by age (06), incomplete laboratory data (32) and for having imaging exams (tomography) unavailable (02), totaling a sample of 390 patients. Of the 390 patients analyzed, 194 were male and 196 female and the mean age of the sample studied was 49.8 years (between 18 and 95 years). The symptoms presented at the time of medical consultation were dry cough (66.9%), fever (58.9%), dyspnea (45.6%), headache (45.1%), myalgia (36.4%), odinofagia (34.8%), asthenaism (31 anosmia (28.9%), ageusia (27.1%), runny nose (23.5%), diarrhea (21.0%), chest pain (13.5%), dizziness (5.1%), abdominal pain (3.8%), productive cough (2.0%), conjunctivitis (1.5%) and rash (1.0%). In conclusion, SARSCOV-2 infection has been increasingly studied for a better understanding of its behavior in the body, in order to promote better care to the population with reduced mortality.